Aridis Pharmaceuticals Inc. financial statements
Aridis Pharmaceuticals Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2022
| Revenue | USD 19.25M | EODHD |
| Net income | −USD 30.75M | EODHD |
| Cash and equivalents | USD 4.88M | EODHD |
| Total debt | USD 6.13M | EODHD |
Aridis Pharmaceuticals Inc. financials on 6ix · Aridis Pharmaceuticals Inc. on 6ix